Company Long-Term Loans and Borrowings: Astria Pharma (ATXS)
Serving as the primary valuation tool, this price chart on GURU.Markets highlights how Astria Therapeutics (ATXS) protects its business through patents and orphan drug status, creating a significant barrier to entry for competitors. Astria Therapeutics (ATXS) minimizes financial risks through the diversification of its clinical trials. The current metric stands at 0.00, while the R&D center focuses on developing the revolutionary STAR-0215 antibody for the treatment of hereditary angioedema.
Astria Pharma (ATXS) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Astria Therapeutics|ATXS - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Astria Corp|ATXS - Company Debts|Debt to Book Value Astria Therapeutics|ATXS - Company Long-Term Debt|Company Current Liabilities Astria Therapeutics|Quick Ratio astriatx.com
- earnings and multiples data:
Analysis of all company metrics:ATXS - astriatx.com
For Astria Therapeutics (ATXS), which possesses high scientific authority in the treatment of rare allergies, the company's long-term debt status reflects its R&D financing strategy. This indicator aggregates all obligations with a maturity exceeding twelve months. An increase in this metric indicates a rising credit burden, which may reduce bottom-line profit. For an investor, the absence of debt coupled with successful clinical trials confirms the financial stability of the business.
Competitors of Astria Therapeutics (ATXS)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|Zenas Biopharma, Inc. - Company Long-Term Debts|IMNM - Company Long-Term Debts|Gossamer Bio, Inc. (GOSS) - Company Long-Term Debt|KALV - Long-Term Debt Volume|Company Long-Term Liabilities SEPN|PVLA (Pieris Pharma) - Amount of Long-Term Liabilities|Company Long-Term Debt Savara Corp (SVRA)|RIGL (Rigel Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debts ANAB (AnaptysBio, Inc.)|Long-Term Debt Volume engene.com (ENGN)|RAPT Therapeutics, Inc. - Company Long-Term Debts|JBIO - Company Long-Term Debts|ACRS (Aclaris) - Company Long-Term Liabilities|Kyverna Therapeutics, Inc - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities TLSA|CABA (cabalettabio.com) - Amount of Long-Term Liabilities|Company Long-Term Debts VTYX|THTX (Theratechnologies, Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debts AVTX (Avalo Therapeutics Inc.)|Eledon Pharmaceuticals, Inc (ELDN) - Long-Term Debt|AGEN - Company Long-Term Debt|Company Long-Term Loans and Borrowings CLYM (climbbio.com)|ZURA: Company Long-Term Debts|aTyr Pharma Inc (ATYR) - Company Long-Term Debts|Company Long-Term Debt Adagene Inc|Ikena Oncology, Inc. - Long-Term Liabilities|Company Long-Term Debts STTK|EQ - Long-Term Debt|Connect Biopharma Holdings Limited - Company Long-Term Liabilities|Company Long-Term Debts Immunic Therapeutics IMUX|ATRA: Company Long-Term Liabilities|InflaRx N.V. - Amount of Long-Term Liabilities|XFOR: Company Long-Term Debts|ACET - Long-Term Debt Volume|CELU (Celularity Inc) - Company Long-Term Debts|Company Long-Term Liabilities INmune Bio Inc (INMB)|Company Long-Term Debt Barinthus Bio (BRNS)|Long-Term Debt Volume Kezar Life Sciences Inc|Company Long-Term Debts SABS (SAB Biotherapeutics)|Company Long-Term Debts akaritx.com AKTX|ENLV: Company Long-Term Liabilities|Q32 Bio Inc. - Amount of Long-Term Liabilities|GOVX (GeoVax Labs Inc) - Company Long-Term Liabilities|Company Long-Term Indebtedness EDSA|Company Long-Term Debt iBio, Inc.|Carisma Tx (CARM) - Long-Term Debt Volume|Company Long-Term Debt XTL Biopharmaceuticals Ltd. (XTLB)|BOLT: Long-Term Liabilities|Company Long-Term Debts HCWB (HCW Biologics)|Company Long-Term Loans and Borrowings APVO|AIM ImmunoTech - Company Long-Term Debts|ADTX - Company Long-Term Debts|GRI Bio (GRI) - Company Long-Term Debt|XORTX Therapeutics Inc - Company Long-Term Loans and Borrowings|Company Long-Term Debt ReShape Lifesciences|Company Long-Term Liabilities Revelation Biosciences Corp (REVB)|Company Long-Term Debts INDP|Company Long-Term Debts scinai.com (SCNI)|CalciMedica - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings AFMD|Allakos Therapeutics - Company Long-Term Debts|Long-Term Debt Volume HOOKIPA Pharma Inc. HOOK|igmbio.com (IGMS) - Company Long-Term Debt|Company Long-Term Liabilities iteostherapeutics.com|Company Long-Term Debt Ocean Biomedical|Company Long-Term Liabilities TC BioPharm (Holdings) Plc (TCBP)|Company Long-Term Liabilities THRD (Third Harmonic Bio, Inc)